Skip to main content
Screener/Healthcare/Biotechnology

RIGL — Rigel Pharmaceuticals, Inc.

NASDAQ
$32.86 (—)
Small CapUnder $50Healthcare
$18.14
$52.24
—
—
EPS (TTM)$18.72
P/E Ratio1.76
Dividend Yield—
Market Cap$607.8M
Volume—
Prev Close$33.37
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$58.8M$8.7M$0.4492.2%14.7%
Q4 '25$69.8M$268.1M$13.5491.5%384.0%
Q3 '25$69.5M$27.9M$1.4693.2%40.2%
Q2 '25$101.7M$59.6M$3.2895.6%58.6%
Q1 '25$53.3M$11.4M$0.6391.7%21.5%
Q4 '24$57.6M$14.3M$0.8089.9%24.9%
Q3 '24$55.3M$12.4M$0.7085.5%22.5%
Q2 '24$36.8M-$1.0M$-0.0692.4%-2.8%
Get Your Daily Market Recap